{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:31:54Z","timestamp":1787070714965,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Telogen effluvium (TE) is self limiting diffuse hair loss occurring 3\u20134 months after a triggering event. There is scarcity of data on TE as possible sequelae of COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We assessed 113 cases of TE occurring after SARS-CoV-2 infection as a retrospective study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Most of the patients belonged to the age group 18\u201330 years and were females (85.8%). Most of the patients (92%) had acute TE. The median duration of hair loss was 2 months. Trichodynia and pruritus were the common associated complaints. Hair pull test was positive in 54.9% patients. Trichoscopy showed short regrowing hairs in 61.2% patients and empty hair follicles in 77.9% patients. Ferritin, vitamin D and Vitamin B12 deficiency was seen in 27.4%, 38.1% and 20.4% patients respectively. TE was seen more commonly with symptomatic COVID infection (93% patients).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>TE occurring after SARS-CoV-2 infection calls for assessment of micronutrient deficiency, as there appears to be an association between COVID-19 infection and nutritional deficiency. Although acute TE is the most common presentation, relapse in chronic TE might also occur as sequelae of COVID-19 infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijt.ijt_38_22","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T15:00:15Z","timestamp":1750690815000},"page":"32-35","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases"],"prefix":"10.4103","volume":"17","author":[{"given":"Namrata","family":"Chhabra","sequence":"first","affiliation":[{"name":"Department of Dermatology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Anju","family":"George","sequence":"additional","affiliation":[{"name":"Department of Dermatology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyaki","family":"Ganguly","sequence":"additional","affiliation":[{"name":"Department of Dermatology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"R1-20250628","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen","year":"1983","journal-title":"J Health Soc Behav"},{"key":"R2-20250628","doi-asserted-by":"crossref","DOI":"10.31128\/AJGP-COVID-32","article-title":"Acute telogen effluvium associated with SARS-CoV-2 infection","volume":"49","author":"Dom\u00ednguez-Sant\u00e1s","year":"2020","journal-title":"Aust J Gen Pract"},{"key":"R3-20250628","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/ijd.15313","article-title":"Telogen effluvium:A sequela of COVID-19","volume":"60","author":"Mieczkowska","year":"2021","journal-title":"Int J Dermatol"},{"key":"R4-20250628","doi-asserted-by":"crossref","first-page":"e14547","DOI":"10.1111\/dth.14547","article-title":"Telogen effluvium related to post severe SARS-Cov-2 infection:Clinical aspects and our management experience","volume":"34","author":"Rizzetto","year":"2021","journal-title":"Dermatol Ther"},{"key":"R5-20250628","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cmi.2020.09.023","article-title":"Clinical sequelae of COVID-19 survivors in Wuhan, China:A single-centre longitudinal study","volume":"27","author":"Xiong","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"R6-20250628","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1111\/jdv.17045","article-title":"SARS-CoV-2-induced telogen effluvium:A multicentric study","volume":"35","author":"Moreno-Arrones","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R7-20250628","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s11845-021-02754-5","article-title":"COVID-19 infection is a major cause of acute telogen effluvium","volume":"191","author":"Sharquie","year":"2022","journal-title":"Ir J Med Sci"},{"key":"R8-20250628","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jdin.2021.07.006","article-title":"Trichodynia and telogen effluvium in COVID-19 patients:Results of an international expert opinion survey on diagnosis and management","volume":"5","author":"Starace","year":"2021","journal-title":"JAAD Int"},{"key":"R9-20250628","first-page":"E01","article-title":"Telogen effluvium:A review","volume":"9","author":"Malkud","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"R10-20250628","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/archderm.1993.01680240096017","article-title":"Telogen effluvium. New concepts and review","volume":"129","author":"Headington","year":"1993","journal-title":"Arch Dermatol"},{"key":"R11-20250628","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(89)70049-9","article-title":"Interferon alfa-2a in the treatment of cutaneous T cell lymphoma","volume":"20","author":"Olsen","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"R12-20250628","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40801-015-0056-z","article-title":"Traditional anticoagulants and hair loss:A role for direct oral anticoagulants?A review of the literature","volume":"3","author":"Watras","year":"2016","journal-title":"Drugs Real World Outcomes"}],"container-title":["International Journal of Trichology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_38_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:35:18Z","timestamp":1787067318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijt.ijt_38_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijt.ijt_38_22","relation":{},"ISSN":["0974-7753","0974-9241"],"issn-type":[{"value":"0974-7753","type":"print"},{"value":"0974-9241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2022-03-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}